Krystal Biotech buy Jefferies Financial Group Inc.
Start price
05.03.25
/
50%
€166.55
Target price
05.03.26
€228.54
Performance (%)
34.31%
End price
06.03.26
€223.70
Summary
This prediction ended on 06.03.26 with a price of €223.70. With a performance of 34.31% the BUY prediction by Jefferies_Financial_ was a big success. Jefferies_Financial_ has a follow-up prediction for Krystal Biotech where he still thinks Krystal Biotech is a Buy. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Krystal Biotech | -8.014% | -8.014% | 134.464% |
| iShares Core DAX® | -1,60 % | 1,52 % | 3,02 % |
| iShares Nasdaq 100 | 1,43 % | 1,16 % | 32,58 % |
| iShares Nikkei 225® | 1,11 % | 1,73 % | 60,58 % |
| iShares S&P 500 | 0,53 % | 2,97 % | 24,14 % |
Comments by Jefferies_Financial_ for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $245.00 price target on the stock.
Ratings data for KRYS provided by MarketBeat
In the thread Trading Krystal Biotech
Die von Jefferies_Financial_ gewählte maximale Laufzeit wurde überschritten